# Eribulin

## Halaven inj 1mg-2mL (Sample)

*藥物代碼*：IHAL0

*給藥途徑*：I

*用法用量*：

Breast cancer, metastatic: I.V.: Eribulin mesylate: 1.4 mg/m2/dose on days 1 and 8 of a 21-day treatment cycle
CrCl >50 mL/minute: No adjustment required.
CrCl 30-50 mL/minute: Reduce to eribulin mesylate 1.1 mg/m2/dose.
CrCl <30 mL/minute: Use has not been studied.

## Halaven inj 1mg-2mL

*藥物代碼*：IHALA

*給藥途徑*：I

*用法用量*：

Breast cancer, metastatic: I.V.: Eribulin mesylate: 1.4 mg/m2/dose on days 1 and 8 of a 21-day treatment cycle
CrCl >50 mL/minute: No adjustment required.
CrCl 30-50 mL/minute: Reduce to eribulin mesylate 1.1 mg/m2/dose.
CrCl <30 mL/minute: Use has not been studied.

